BALDINI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 16.174
AS - Asia 8.113
EU - Europa 6.019
SA - Sud America 1.490
AF - Africa 521
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 11
Totale 32.385
Nazione #
US - Stati Uniti d'America 15.666
SG - Singapore 2.549
CN - Cina 2.522
IT - Italia 1.567
HK - Hong Kong 1.545
BR - Brasile 1.239
SE - Svezia 1.014
DE - Germania 783
BG - Bulgaria 593
VN - Vietnam 539
GB - Regno Unito 448
CA - Canada 381
FI - Finlandia 322
RU - Federazione Russa 277
TR - Turchia 251
FR - Francia 200
IN - India 188
NL - Olanda 182
CI - Costa d'Avorio 155
UA - Ucraina 128
NG - Nigeria 104
AT - Austria 103
JP - Giappone 92
SN - Senegal 87
ES - Italia 85
MX - Messico 82
KR - Corea 74
AR - Argentina 73
BD - Bangladesh 61
PL - Polonia 57
AU - Australia 52
CH - Svizzera 52
BE - Belgio 51
MA - Marocco 43
IQ - Iraq 41
ZA - Sudafrica 40
EC - Ecuador 37
CO - Colombia 36
ID - Indonesia 36
CL - Cile 27
IE - Irlanda 24
UZ - Uzbekistan 24
KE - Kenya 22
LT - Lituania 22
VE - Venezuela 22
SA - Arabia Saudita 21
RO - Romania 18
TW - Taiwan 18
PE - Perù 17
DZ - Algeria 16
GR - Grecia 16
PK - Pakistan 16
PY - Paraguay 15
EG - Egitto 14
IL - Israele 14
MY - Malesia 14
UY - Uruguay 13
PT - Portogallo 12
LB - Libano 11
PH - Filippine 11
DK - Danimarca 10
TN - Tunisia 10
BO - Bolivia 9
CZ - Repubblica Ceca 8
EU - Europa 8
IR - Iran 8
AE - Emirati Arabi Uniti 7
KG - Kirghizistan 7
KZ - Kazakistan 7
NP - Nepal 7
AO - Angola 6
AZ - Azerbaigian 6
BJ - Benin 6
DO - Repubblica Dominicana 6
NO - Norvegia 6
PS - Palestinian Territory 6
AL - Albania 5
AM - Armenia 5
CR - Costa Rica 5
JM - Giamaica 5
JO - Giordania 5
LK - Sri Lanka 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
BY - Bielorussia 4
ET - Etiopia 4
HN - Honduras 4
HR - Croazia 4
HU - Ungheria 4
LU - Lussemburgo 4
MD - Moldavia 4
PA - Panama 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BS - Bahamas 3
GT - Guatemala 3
IS - Islanda 3
OM - Oman 3
Totale 32.340
Città #
Ashburn 1.701
Woodbridge 1.634
Hong Kong 1.517
Singapore 1.349
Dallas 1.263
Ann Arbor 1.127
Houston 1.045
Fairfield 992
Santa Clara 981
Chandler 897
Shanghai 647
Beijing 603
Sofia 590
New York 465
Seattle 444
Wilmington 380
Boardman 371
Milan 338
Cambridge 333
Princeton 277
Munich 271
Ottawa 267
Los Angeles 256
Lawrence 234
Medford 218
Nanjing 167
Abidjan 155
Serra 154
Florence 143
Jacksonville 142
Des Moines 139
Hefei 129
London 123
Ho Chi Minh City 121
São Paulo 113
Council Bluffs 112
Izmir 108
Frankfurt am Main 107
Istanbul 105
Lagos 103
Dearborn 102
Dong Ket 96
Redondo Beach 91
Dakar 87
Bremen 85
Helsinki 79
Rome 79
Vienna 77
Buffalo 76
Turku 74
San Diego 70
Hanoi 62
Pisa 59
Redwood City 57
Seoul 57
Ogden 55
Pune 54
Tokyo 54
Amsterdam 50
Nanchang 50
Fuzhou 44
Falls Church 42
Nuremberg 42
Warsaw 42
Düsseldorf 41
Kunming 41
Lancaster 41
Shenyang 40
Rio de Janeiro 38
Bern 37
Guangzhou 37
Belo Horizonte 36
Brussels 35
Hebei 34
Boulder 33
Chicago 32
Jüchen 31
Paris 31
Changsha 30
Marseille 30
Denver 28
San Jose 27
Jiaxing 26
Phoenix 26
Atlanta 25
Brooklyn 25
Livorno 25
Hangzhou 24
Montreal 24
San Francisco 24
Cascina 23
Dublin 23
Seville 23
Tianjin 23
Boston 22
Brasília 22
Tashkent 22
Toronto 22
Curitiba 21
Mumbai 21
Totale 22.748
Nome #
Sjögren syndrome 1.344
Eosinophilic granulomatosis with polyangiitis and laryngeal involvement: Review of the literature and a cross-sectional prospective experience 304
IN THE CHRONIC MYELOID LEUKEMIA THE SALIVARY PROTEOMICS RECAPITULATES SOME ASPECTS OF THE LEUKEMIC STEM CELL. LA CELLULA STAMINALE LEUCEMICA E LA PROTEOMICA SALIVARE: IL MODELLO DELLA LEUCEMIA MIELOIDE CRONICA 219
Correspondence between salivary proteomic pattern and clinical course in primary Sjogren syndrome and non-Hodgkin's lymphoma: a case report 208
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus. 196
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 188
Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren's Syndrome 187
Classification criteria 186
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 183
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 182
A proposal of simple calculation (ERI calculator) to predict the early response to TNF-a blockers therapy in rheumatoid arthritis 179
Autoimmune diseases and myeloid hematological disorders: a possible pathogenetic relationship 177
Skin manifestations and sjögren’s syndrome 176
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. 175
Connexin Expression in Human Minor Salivary Glands: An Immunohistochemical Microscopy Study 174
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME 173
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review 171
miRNA-mediated regulation of Mucin-type O-Glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren's syndrome 171
[Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome] 170
Focus on the Involvement of the Nose and Paranasal Sinuses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Nasal Cytology Reveals Infiltration of Eosinophils as a Very Common Feature 169
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 168
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 167
Efficacy and safety of rituximab in HCV-related mixed cryoglobulinemia 166
Skin manifestations and cryoglobulinemia 166
Anti-Sm and anti-RNP antibodies 165
A Clinical Prediction Rule for Lymphoma Development in Primary Sjogren's Syndrome 164
MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia. [MALDI-TOF e SELDI-TOF: due tecniche “tandem” per l’individuazione di potenziali biomarker nella fibromialgia] 163
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers 161
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. 160
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience. 160
Proteomics approach as a tool for salivary fingerprint characterization able to discriminate different Sjögren’s syndrome phenotype. 160
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 160
Biomarkers for Sjögren's syndrome 160
Muscular vasculitis confined to lower limbs: description of two case reports and a review of the literature 160
Undifferentiated connective tissue diseases (UCTD) 159
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome. 158
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases 153
Classification criteria for Sjogren's syndrome: A critical review. 152
Classification criteria in Sjögren’s syndrome 150
Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients 150
Classification criteria for Sjogren's syndrome: A critical review. 149
The association of Sjögren syndrome and autoimmune thyroid disorders 149
Ultra-High Frequency Ultrasound, A Promising Diagnostic Technique: Review of the Literature and Single-Center Experience 149
Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. 148
Mucocutaneous manifestations of Sjögren's Syndrome 146
Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. 146
Proteomic analysis of the saliva: A clue for understanding primary from secondary Sjogren's syndrome? 146
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 145
Clinical manifestations and treatment of Churg-Strauss syndrome 145
Treatment of chronic hepatitis C infection with cryoglobulinemia. 142
The economic impact of gout: a systematic literature review. 139
Primary Sjogren's Syndrome: clinical and serological feature of a single centre [Sindrome di Sjogren primitiva: Descrizione clinica e sierologica di una casistica monocentrica] 138
Myeloid neoplasms and autoimmune diseases: markers of association 138
Proteomic diagnosis of Sjögren's syndrome 137
Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome 136
Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? 136
Sjögren's syndrome: state of the art on clinical practice guidelines 136
Analysis of the evolution of UCTD to defined CTD after a long-term follow-up. 134
Salivary histidine-rich glycoprotein: a novel putative biomarker for autoimmune disease. 134
Ultra-High Frequency Ultrasound (Uhfus) Applications in Sjogren Syndrome: Narrative Review and Current Concepts 134
Outcome of pregnancy in Italian patients with primary Sjögren syndrome 133
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 132
Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome 132
Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome. 132
Artrite reumatoide e analisi proteomica della saliva 131
A Clinical prediction rule for lymphoma development in primary and secondary Sjogren’s syndrome. 130
Emerging trends in Sjögren's syndrome: basic and translational research. 129
Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine 129
Salivary Cystatin C and the imbalance between cysteine proteases and their inhibitors in Churg Strauss Syndrome. 128
One year in review 2019: Sjögren’s syndrome 128
COVID-19: the new challenge for rheumatologists 128
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 127
Patterns of inflammation and dysfunction in pSS: identification of proteomic salivary biomarkers correlated with different disease phenotypes. 127
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2 127
Advances in salivary gland ultrasonography in primary Sjögren's syndrome 126
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 126
The CoV-2 outbreak: how hematologists could help to fight Covid-19 126
THU0264 MYELOID MALIGNANCIES, SYSTEMIC AUTOIMMUNE DISEASES AND CARDIOVASCULAR RISK: AN UNDER-REPORTED ASSOCIATION? 126
Aderenza allo screening per il cancro della cervice uterina in una coorte italiana di donne affette da LES [Adherence to cervical cancer screening in an Italian SLE cohort] 125
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 125
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 124
Detection of potential markers of primary fibromyalgia syndrome in human saliva 124
Current Concepts on Classification Criteria and Disease Status Indexes in Sjögren’s Syndrome 123
Histidine proline rich glycoprotein (HPRG) e sindrome di Sjoegren primitiva: un ruolo patogenetico nella formazione degli infiltrati ghiandolari? 123
Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis 122
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis 122
Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome 122
One year in review 2018: Sjögren's syndrome 122
Eosinophilic granulomatosis with polyangiitis with heterozygous familial hypercholesterolemia: A tricky therapeutic approach with omalizumab and evolocumab 121
Undifferentiated connective tissue diseases in 2004 119
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients 119
Mikulicz's disease: a long-term follow-up case report. 118
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases. 118
One year in review 2020: vasculitis 118
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 117
Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham's Chorea: A Multicenter Prospective Study 116
Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis? 116
LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus 116
Chronic skin lichenification as unusual presentation of eosinophilic granulomatosis with polyangitis: case report and literature review 116
Updates on Sjögren's syndrome: from proteomics to protein biomarkers 115
Totale 15.919
Categoria #
all - tutte 97.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.100 0 0 0 0 0 178 77 106 173 116 112 338
2021/20222.647 47 181 39 170 481 380 98 137 137 99 161 717
2022/20233.435 440 430 248 288 408 380 43 237 580 50 265 66
2023/20242.607 240 241 280 178 387 507 140 72 54 74 131 303
2024/20258.298 74 322 120 405 701 1.001 801 470 808 1.056 962 1.578
2025/20266.225 693 1.279 1.423 886 1.141 803 0 0 0 0 0 0
Totale 33.298